Under 21, any sex, with Allergy Drug or Allergic Reaction. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
True Allergy (Consistent With an IgE-mediated Reaction)Primary· Baseline
Cutaneous reactions (hives, urticarial, skin redness, rash) within 6 h of the dose or Anaphylaxis or anaphylactoid reaction within 6 h of the dose
Group
Value
95% CI
Medication Allergies
135
Unlikely True Allergy (Less Relevant With an IgE-mediated Reaction)Secondary· Baseline
Cutaneous reactions (rash, skin redness) longer than 6 h after the dose
Group
Value
95% CI
Medication Allergies
73
Not True Allergy (Not Related to IgE-mediated Reaction)Secondary· Baseline
Allergy listed in the medical record but instead: Recognized adverse effect of the medication, Family history of allergy, Based on medical history or other reasons, or Parents reported their child has no allergy
Group
Value
95% CI
Medication Allergies
93
Sponsor's own description
The study will only involve identification of the listed allergies from the electronic medical record and investigation into the symptoms that prompted this allergy listing. The purpose is to evaluate demographics and prevalence of allergies in patients presenting for surgery, evaluate the medical decision making process behind allergy identification, and determine its potential impact on perioperative care. The participants will be asked to complete a survey in REDCap using an iPad during the visit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nationwide Children's Hospital
Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05670756.